Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China · Delayed Price · Currency is CNY 31.70
-0.43 (-1.34%)
May 19, 2026, 4:00 PM EDT
SHE:301246 Revenue
Hubei Hongyuan Pharmaceutical Technology had revenue of 703.53M CNY in the quarter ending March 31, 2026, with 62.31% growth. This brings the company's revenue in the last twelve months to 2.21B, up 24.26% year-over-year. In the year 2025, Hubei Hongyuan Pharmaceutical Technology had annual revenue of 1.94B with 9.53% growth.
Revenue (ttm)
2.21B
Revenue Growth
+24.26%
P/S Ratio
5.69
Revenue / Employee
1.02M
Employees
2,169
Market Cap
12.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.94B | 168.75M | 9.53% |
| Dec 31, 2024 | 1.77B | -284.16M | -13.83% |
| Dec 31, 2023 | 2.05B | -8.84M | -0.43% |
| Jan 1, 2023 | 2.06B | 485.86M | 30.79% |
| Jan 1, 2022 | 1.58B | 274.92M | 21.10% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition